| 상품명칭 |
(3S)-테트라하이드로푸란-3-일[(2S,3R)-4-{[(4-아미노페닐)설포닐](2-메틸프로필)아미노}-1-페닐-3-(포스포노옥시)부탄-2-일]카르바메이트 |
| 별명 |
;((1S,2R)-3-(((4-아미노페닐)설포닐)(2-메틸프로필)아미노)-1-(페닐메틸)-2-(포스포노옥시)프로필)카르바믹산 C-((3S)-테트라하이드로-3-푸라닐) 에스테르; (3S)-테트라하이드로푸란-3-일[(2S,3R)-4-{[(4-아미노페닐)설포닐](이소부틸)아미노}-1-페닐-3-(포스포노옥시)부탄-2-일]카르바메이트; 226700-79-4; 포삼프레나비르 ; 개르, 433, 908 |
| 영문 이름 |
(3S)-tetrahydrofuran-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-1-phenyl-3-(phosphonooxy)butan-2-yl]carbamate; ((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)carbamic Acid C-((3S)-Tetrahydro-3-furanyl) Ester; (3S)-Tetrahydrofuran-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](isobutyl)amino}-1-phenyl-3-(phosphonooxy)butan-2-yl]carbamate; 226700-79-4; Fosamprenavir ; GW 433 908 |
| 분자식 |
C25H36N3O9PS |
| 분자량 |
585.6068 |
| InChI |
InChI=1/C25H36N3O9PS/c1-18(2)15-28(39(33,34)22-10-8-20(26)9-11-22)16-24(37-38(30,31)32)23(14-19-6-4-3-5-7-19)27-25(29)36-21-12-13-35-17-21/h3-11,18,21,23-24H,12-17,26H2,1-2H3,(H,27,29)(H2,30,31,32)/t21-,23-,24+/m0/s1 |
| cas번호 |
226700-79-4 |
| 분자 구조 |
아미노}-1-페닐-3-(포스포노옥시)부탄-2-일]카르바메이트](https://images-a.chemnet.com/suppliers/chembase/cas117/226700-79-4.png)
|
| 밀도 |
1.4g/cm3 |
| 굴절 지수 |
1.611 |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
KR
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
MY
NL
NO
PL
PT
RU
SA
TR
